ArticleTranslational cancer research2026
Bioinformatics identification of adenosylhomocysteinase (AHCY) as a regulator of ferroptosis in nasopharyngeal carcinoma cells via the Hippo-Yes-associated protein (Hippo-YAP) pathway.
Article in Translational cancer research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Nasopharyngeal carcinoma (NPC) is a widely prevalent malignant tumor with a marked tendency toward metastasis and recurrence. Ferroptosis-related genes (FRGs) are critically involved in the pathogenesis of NPC. This study aims to employ bioinformatics analysis methods to identify key genes influencing the malignant progression of NPC and to investigate the regulatory mechanisms of these genes. Methods: Bulk RNA sequencing datasets (GSE53819, GSE61218, GSE64634, GSE12452, and GSE102349) and a single-cell RNA sequencing dataset (GSE150825) were downloaded from the Gene Expression Omnibus. Integrated bioinformatics analyses-including differential expression analysis, weighted gene co-expression network analysis, machine learning, and survival analysis-were conducted to identify key FRGs associated with NPC. Intracellular expression levels of adenosylhomocysteinase (AHCY), acyl-CoA synthetase long chain family member 4, glutathione peroxidase 4, macrophage stimulating 1, and Yes1 associated transcriptional regulator were detected through western blot. Cell viability was assessed using the cell counting kit-8; cell death was determined by flow cytometry; and cell migration and invasion were evaluated using wound-healing and Transwell assays. Intracellular reactive oxygen species levels were determined using the fluorescent probe 2',7'-dichlorodihydrofluorescein diacetate, and malondialdehyde and glutathione levels were detected using their respective detection kits. Results: Four key FRGs-isocitrate dehydrogenase 1, AHCY, endothelial PAS domain-containing protein 1 (EPAS1), and ARHGEF26 antisense RNA 1-were identified. Survival analysis of publicly available cohorts highlighted AHCY and EPAS1 as potential biomarkers for survival in patients with NPC. We selected AHCY for further Conclusions: Our
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.